Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab')2 fragment derived from equine polyclonal antibodies. - Salinas F; Marelli BE; Sanguineti S; Goldbaum F; Muñoz L; Etchevers L; Silvestrini P; Notaro US; Salvetti NR; Zylberman V; Ortega HH (Toxicology and applied pharmacology, 2022)